DECEMBER 16, 2015 As published in the San Antonio Business Journal By W. Scott Bailey The People’s Republic of China has awarded a Certificate of Invention Patent to bioAffinity Technologies for its proprietary CyPath® assay, which could have a profound impact on cancer detection globally. The San Antonio-based biotech company’s latest accomplishment could especially affect […]
DECEMBER 2, 2015 As published in the CEO/CFO Magazine Interview conducted by: Lynn Fosse, Senior Editor, CEO/CFO Magazine, Published – November 30, 2015 CEO/CFO: Ms. Zannes, would you tell us the overall vision at bioAffinity Technologies? Ms. Zannes: bioAffinity Technologies is committed to continual scientific exploration, transparency and collaboration, and the development and commercialization of […]
OCTOBER 23, 2015 As published in the San Antonio Business Journal By W. Scott Bailey Reporter/Project Coordinator San Antonio Business Journal San Antonio’s bioAffinity Technologies was invited to present its novel technology for the detection and diagnosis of early-stage lung cancer at the 2015 Pharmaceutical/Medtech Dealmaking Symposium in Chicago last week. bioAffinity President and CEO […]
OCTOBER 20, 2015 As published in the San Antonio Business Journal By W. Scott Bailey San Antonio’s bioscience industry has gained more critical exposure courtesy of bioAffinity Technologies. The Alamo City company was invited to present its novel technology for the detection and diagnosis of early-stage lung cancer at the 2015 Pharmaceutical/Medtech Dealmaking Symposium in […]
OCTOBER 12, 2015 As published in the San Antonio Business Journal By W. Scott Bailey bioAffinity Technologies Inc., a development-stage biotech company launched in San Antonio in March 2014, has found solid footing in South Texas. It’s also found interest from East Coast investors who could look to pour more money into an Alamo City […]
OCTOBER 4, 2015 By Maria Zannes, President & Chief Executive Officer (SAN ANTONIO, TX ) Early detection of cancer prolongs life. Each of us at bioAffinity Technologies has seen this firsthand. Our brothers, sisters, parents, friends and patients, and many of us personally, have benefited from early cancer detection. We have seen the triumph when […]